Beam Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31.7M | 114.1M | 9.7M | 8.5M | 7.5M | 30.1M | 14.3M | 11.8M |
| Cost of Goods Sold | 11.1M | 5.7M | 109.8M | 101.8M | 98.8M | 101.4M | 94.3M | 87.0M |
| Gross Profit | 20.7M | 108.4M | -100.1M | -93.3M | -91.3M | -71.4M | -80.0M | -75.3M |
| R&D Expenses | 104.5M | 99.3M | 109.8M | 101.8M | 98.8M | 101.4M | 94.3M | 87.0M |
| Operating Expenses | 127.9M | 125.9M | 26.7M | 26.9M | 27.9M | 28.7M | 26.5M | 29.6M |
| Operating Income | -107.2M | -17.4M | -126.8M | -120.2M | -119.3M | -100.0M | -106.5M | -104.9M |
| Other Income / Gains | 12.9M | 261.7M | 14.1M | 17.9M | 10.0M | 9.7M | 9.8M | 13.9M |
| Net Income | -94.3M | 244.3M | -112.7M | -102.3M | -109.3M | -90.4M | -96.7M | -91.1M |
| EPS (Diluted) | -0.91 | 2.37 | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 | -1.11 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.652 | 0.95 | -10.319 | -11.02 | -12.228 | -2.374 | -5.606 | -6.394 |
| General And Administrative Expenses | 34.4M | 26.6M | 26.7M | 26.9M | 27.9M | 28.7M | 26.5M | 29.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 34.4M | 26.6M | 26.7M | 26.9M | 27.9M | 28.7M | 26.5M | 29.6M |
| Other Expenses | -11.1M | 0 | -109.8M | -101.8M | -98.8M | -101.4M | -94.3M | -87.0M |
| Cost And Expenses | 139.0M | 131.6M | 136.5M | 128.6M | 126.8M | 130.1M | 120.8M | 116.7M |
| Interest Income | 9.9M | 0 | 10.9M | 0 | 9.9M | 10.9M | 12.1M | 14.2M |
| Interest Expense | 0 | 10.6M | 0 | 0 | 0 | 0 | 0 | — |
| Depreciation And Amortization | 5.6M | 5.7M | 5.6M | 5.5M | 5.5M | 5.4M | 5.5M | 5.6M |
| Ebitda | -88.7M | 260.6M | -107.2M | -96.8M | -103.7M | -84.9M | -91.2M | -85.4M |
| Ebitdaratio | -2.795 | 2.284 | -11.051 | -11.428 | -13.888 | -2.824 | -6.391 | -7.258 |
| Operating Income Ratio | -3.378 | -0.153 | -13.076 | -14.192 | -15.969 | -3.327 | -7.464 | -8.911 |
| Income Before Tax | -94.3M | 244.3M | -112.7M | -102.3M | -109.3M | -90.4M | -96.7M | -91.0M |
| Income Before Tax Ratio | -2.972 | 2.141 | -11.624 | -12.083 | -14.628 | -3.005 | -6.775 | -7.731 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39K |
| Net Income Ratio | -2.972 | 2.141 | -11.624 | -12.083 | -14.628 | -3.005 | -6.775 | -7.735 |
| Epsdiluted | -0.91 | 2.33 | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 | -1.11 |
| Weighted Average Shs Out | 103.3M | 102.9M | 102.6M | 102.0M | 88.0M | 82.8M | 82.4M | 82.3M |
| Weighted Average Shs Out Dil | 103.3M | 104.9M | 102.6M | 102.0M | 88.0M | 82.8M | 82.4M | 82.3M |